A new physical form of proteins developed by researchers at The University of Texas at Austin could drastically improve treatments for cancer and other diseases, as well as overcome some of the largest challenges in therapeutics: delivering drugs to patients safely, easily and more effectively.
Go to Source
Researchers at Duke University Medical Center have created synthetic nanoparticles that target lymph nodes and greatly boost vaccine responses, said lead author Ashley St. John, Ph.D., a researcher at Duke-NUS Graduate Medical School.
Go to Source
(PhysOrg.com) — The best performing solar cells are those that are thick enough to absorb light from the entire solar spectrum, while the cheapest solar cells are thin ones, since they require less, and potentially cheaper, material. In an attempt to combine the best of both worlds, a team of scientists has outlined designs for [...]
(PhysOrg.com) — By tweaking the smallest of parts, a trio of University at Buffalo engineers is hoping to dramatically increase the amount of sunlight that solar cells convert into electricity.
Go to Source
Publisher’s note: Adherence to TB drugs is an major issue.
US technology firm Proteus Biomedical has launched a smart pill with an integrated microchip that tracks patients’ adherence to their medication.
Go to Source
Mendeley Related Research
4
ReadersReducing the immunogenicity of protein therapeutics.Array (2009)82
Readers8
Readers0
Readers10
ReadersProteases as therapeutics.Array (2011)
Money Transfer
